Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will there be a generic loreev available?Combivent generic equivalent?Dabrafenib btd date 2023?What is the difference between apixaban and apixaban accord?Atorvastatin side effects heart palpitations?
See the DrugPatentWatch profile for kevzara
Kevzara (sarilumab) is given as a subcutaneous injection under the skin, typically in the thigh, abdomen, or upper arm. Patients or caregivers administer it at home using pre-filled syringes or autoinjectors. It's approved for adults with moderately to severely active rheumatoid arthritis.
Standard starting dose is 200 mg every 2 weeks, given as two 100 mg/1.1 mL injections (one in each side of the body). Doctors may reduce to 150 mg every 2 weeks if needed for side effects like low neutrophils or liver enzyme elevation. Inadequate response prompts dose increase or switch to other therapies.[1]
Keep refrigerated at 36-46°F (2-8°C) in original carton. Can stay at room temperature up to 30°C (86°F) for 24 hours max. Do not freeze, shake, or expose to light. Let warm to room temperature for 30 minutes before injecting. Discard if expired or mishandled.[1]
Adults self-administer after training. Children under 18 need adult supervision. Skip dose if infection suspected or blood tests show issues (e.g., ANC <1000/mm³); consult doctor. First dose in office for monitoring.[1] Sources [1]: Kevzara Prescribing Information (FDA)
Other Questions About Kevzara :